France's Transgene confirms fund raising of up to 150 million euros

Following press speculation that the French biopharmaceutical group was looking to increase its financial based via a rights issue, Transgene announced that it was indeed aiming to strengthen its equity capital structure to finance its strategy to become an integrated biopharmaceutical company by 2015.

At this stage the characteristics envisaged for the fund-raising are as follows:

* the fund raising would take the form of a rights issue;